Advertisement

Erythrocyte Polyamines: Their Diagnostic and Therapeutic Importance in Human Neuro-Oncology

  • J.-Ph. Moulinoux
  • V. Quemener
  • J. Théron
  • R. Havouis
  • F. Darcel
  • Y. Guegan
  • P. Courtheoux
  • M. Chatel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 250)

Abstract

In the last few years, the clinical interest in polyamine metabolism in oncology has been amplified and numerous works have been carried out in two main fields: one related to the diagnostic interest in polyamine determination in pathological tissues and in biological fluids of the organism (1), the other concerning the synthesis and clinical use of new drugs which could modify the metabolism of polyamines with consequence for tumor growth (2).

Keywords

Glioma Patient Malignant Brain Tumor Glioblastoma Patient Polyamine Metabolism Polyamine Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G. Scalabrino and M.E. Ferioli, Polyamine in mammalian tumors, in “Advances in Cancer Research”, Vol 35 & 36, Academic Press Inc., New York (1982).Google Scholar
  2. 2.
    P. P. McCann, A. E. Pegg and A. Sjoerdsma, “Inhibition of Polyamine Metabolism”, Academic Press Inc., New York (1988)Google Scholar
  3. 3.
    D. H. Russell, Increased polyamine concentrations in the urine of cancer patients, Nature, 233: 144–145 (1971).Google Scholar
  4. 4.
    L. J. Marton, M. S. Edwards, V. A. Levin, W. P. Lubich, CSF polyamines: a new and important means of monitoring patients with medulloblastoma, Cancer, 47: 757–760 (1981).PubMedCrossRefGoogle Scholar
  5. 5.
    O. M. Rennert and J. B. Shukla, Polyamine in health and disease, in: “Advances in Polyamine Research”, R.A. Campbell, D. R. Morris, D. Bartos, G.D. Davex and F. Bartos, eds., Raven Press, New/York (1978)Google Scholar
  6. 6.
    J-Ph. Moulinoux, V. Quemener and G-A. Quash, In vitro studies on the entry of polyamines into normal red blood cells, Biochimie, 66: 385–393 (1984).PubMedCrossRefGoogle Scholar
  7. 7.
    J-Ph. Moulinoux, V. Quemener, A-M. Roch, L. Toujas and G-A. Quash, Red blood cell free polymaines in mice bearing the Lewis lung carcinoma (3LL) and in patients with bronchopulmonary cancer, Int. J. Cancer, 34: 277–281 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    J-Ph. Moulinoux, V. Quemener and Y. Chambon, Evolution of red blood cell polyamine levels in partially hepatectomized rat, Eur. J. Cancer, 23: 237–244(1987).CrossRefGoogle Scholar
  9. 9.
    J-Ph. Moulinoux, D. Delamaire, B. Beau, V. Quemener, P. Brissot, Y. Deugnier, Y. Chambon and M. Bourel, Diagnosis value of erythrocyte free polyamines and histaminemia in malignant hepatic tumors, Clin. Chim. Acta, 145: 77–87 (1985).PubMedCrossRefGoogle Scholar
  10. 10.
    V. Quemener, E. Le Gall, C. Edan and J-Ph. Moulinoux, Red blood cell polyamine levels in children with acute leukemia: their clinical interest in disease staging and monitoring therapy efficiency, Cancer J., 4: 174–179 (1986).Google Scholar
  11. 11.
    J-Ph. Moulinoux, V. Quemener, M. Chatel and F. Darcel, Polyamines in human brain tumors: a correlative study between tumor, CSF and red blood cell polyamine levels, J. Neuro-Oncoloqy (JNO), 2: 153–158 (1984).Google Scholar
  12. 12.
    J-Ph. Moulinoux, V. Quemener, H. Hercouet, F. Darcel and M. Chatel, Red blood cell polyamines in malignant glioma patients: spermidine and spermine blood levels, and tumor evolution, in: “Biology of Brain Tumor”, Martinus Nijhoff Publishers, Boston (1986).Google Scholar
  13. 13.
    M. Chatel, F. Darcel, V. Quemener and J-Ph. Moulinoux, Red blood cell polyamines as biochemical markers of supratentorial malignant gliomas, Anticancer Res., 7: 33–38 (1987).PubMedGoogle Scholar
  14. 14.
    J-Ph. Moulinoux, V. Quemener, F. Darcel and M. Chatel, Red blood cell polyamine levels in the long term follow-up of malignant glioma patients, in: “Brain Oncology: Biology, Diagnosis and Therapy”, Martinus Nijhoff Publishers, Boston (1987).Google Scholar
  15. 15.
    J. Theron, J-Ph. Moulinoux, A. Casasco, V. Quemener, P. Courtheoux and J-M. Derlon, Intra-arterial chemotherapy with BCNU. Correlations between tumor growth and RBC polyamine levels, in: “Brain Oncology: Biology, Diagnosis and Therapy”, Martinus Nijhoff Publishers, Boston (1987).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • J.-Ph. Moulinoux
    • 1
  • V. Quemener
    • 1
  • J. Théron
    • 2
  • R. Havouis
    • 1
  • F. Darcel
    • 1
  • Y. Guegan
    • 1
  • P. Courtheoux
    • 2
  • M. Chatel
    • 1
  1. 1.Groupe de Recherche en Thérapeutique AnticancéreuseCHU of RennesFrance
  2. 2.Groupe de Recherche en Thérapeutique AnticancéreuseCHU of CaenFrance

Personalised recommendations